- Home
- GXAI vs TNON Comparison
GXAI vs TNON Comparison
Compare GXAI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- TNON
- Stock Information
- Founded
- GXAI 2021
- TNON 2012
- Country
- GXAI United States
- TNON United States
- Employees
- GXAI N/A
- TNON N/A
- Industry
- GXAI
- TNON Medical Specialities
- Sector
- GXAI
- TNON Health Care
- Exchange
- GXAI Nasdaq
- TNON Nasdaq
- Market Cap
- GXAI 7.5M
- TNON 6.7M
- IPO Year
- GXAI 2023
- TNON 2022
- Fundamental
- Price
- GXAI $2.00
- TNON $1.79
- Analyst Decision
- GXAI
- TNON Strong Buy
- Analyst Count
- GXAI 0
- TNON 2
- Target Price
- GXAI N/A
- TNON $16.00
- AVG Volume (30 Days)
- GXAI 2.3M
- TNON 153.6K
- Earning Date
- GXAI 11-14-2024
- TNON 03-11-2025
- Dividend Yield
- GXAI N/A
- TNON N/A
- EPS Growth
- GXAI N/A
- TNON N/A
- EPS
- GXAI N/A
- TNON N/A
- Revenue
- GXAI $2,979.00
- TNON $3,315,000.00
- Revenue This Year
- GXAI N/A
- TNON $29.03
- Revenue Next Year
- GXAI N/A
- TNON $100.29
- P/E Ratio
- GXAI N/A
- TNON N/A
- Revenue Growth
- GXAI N/A
- TNON 38.30
- 52 Week Low
- GXAI $1.01
- TNON $1.65
- 52 Week High
- GXAI $19.20
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- GXAI 44.91
- TNON 39.49
- Support Level
- GXAI $1.62
- TNON $1.65
- Resistance Level
- GXAI $2.03
- TNON $2.30
- Average True Range (ATR)
- GXAI 0.36
- TNON 0.16
- MACD
- GXAI -0.13
- TNON 0.01
- Stochastic Oscillator
- GXAI 20.54
- TNON 21.57
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.